Method and system for producing a substance or a signal with a coagulating or anticoagulant effect
| Title: | Method and system for producing a substance or a signal with a coagulating or anticoagulant effect |
|---|---|
| Patent Number: | 9,421,225 |
| Publication Date: | August 23, 2016 |
| Appl. No: | 12/633271 |
| Application Filed: | December 08, 2009 |
| Abstract: | The invention concerns a method and a system for producing a signal, in particular an electric signal, or a substance having a coagulating or anticoagulant effect. The method is characterized in that it is based on a source substance with coagulating effect, in particular, Ca++ ions, or an anticoagulant affect, in particular heparin. The method consists in: transforming the electromagnetic field derived from said source substance located in the chamber, into a signal, in particular an electric signal, using a transducer-receiver sensing the electromagnetic field; applying to a receiving substance located in the chamber, in particular water or a water-ethanol mixture or homeopathic granules, said signal derived from said transducer-receiver, using a transducer-transmitter. After said treatment, the receiving substance, initially inactive, has a coagulating or anticoagulant effect. |
| Inventors: | Benveniste, Jacques (Paris, FR); Guillonnet, Didier (Cagnes-sur-mer, FR) |
| Assignees: | DiGiBio (Paris, FR) |
| Claim: | 1. A method comprising: contacting a composition comprising an isolated coagulating agent or an isolated anticoagulating agent with an electric field, a magnetic field, or an electromagnetic field; transforming the field to produce a signal by employing a transducer-receiver, the signal being characteristic of the isolated coagulating agent or isolated anticoagulating agent; applying the signal to a biological system devoid of the isolated coagulating agent or isolated anticoagulating agent by employing a transducer-transmitter; wherein, after applying, the biological system can cause or undergoes coagulation or anticoagulation. |
| Claim: | 2. The method of claim 1 , wherein the coagulating agent is calcium ion. |
| Claim: | 3. The method of claim 1 , wherein the anticoagulating agent is heparin. |
| Claim: | 4. The method of claim 1 , wherein the biological system is blood or plasma. |
| Claim: | 5. The method of claim 1 , wherein applying comprises applying the signal to a substance that can then be administered to a biological system. |
| Claim: | 6. The method of claim 5 , wherein the substance is a homeopathic substance. |
| Claim: | 7. The method of claim 1 , wherein the signal is an electric signal. |
| Claim: | 8. A method comprising: contacting a composition comprising calcium ion or heparin with an electric field, a magnetic field, or an electromagnetic field; transforming the field to produce a signal by employing a transducer-receiver, the signal being characteristic of calcium or heparin; applying the signal to a biological system devoid of calcium ion or heparin by employing a transducer-transmitter; wherein, after applying, the biological system can produce or undergo coagulation or anticoagulation. |
| Patent References Cited: | 4095168 June 1978 Hlavka 5110727 May 1992 Oberhardt 5583432 December 1996 Barnes 5752514 May 1998 Okamura et al. 44 32 429 March 1996 WO 94/17406 August 1994 WO 96/08200 March 1996 WO 96/10740 April 1996 WO 00/17638 March 2000 |
| Primary Examiner: | Merkling, Sally |
| Attorney, Agent or Firm: | Merchant & Gould P.C. |
| Accession Number: | edspgr.09421225 |
| Database: | USPTO Patent Grants |
| Language: | English |
|---|